Search
Subscribe
-
Latest Tweets
@Maren_Bannon Pricing risk + Liquidity Risk Across existing portfolio Value drivers defying market conditions - 6 hours ago
This is a joy to see 🙏 https://t.co/NSAE44iHKH - 2 weeks ago
@SexyLikeMeiosis You’ve allowed an emotion to flow freely, released oxytocin endorphins in the process and flushed cortisol 😭♥️ - 2 weeks ago
@mkobach That consciousness is a fundamental characteristic of the universe. Well some days I do some days I don’t :-) - 2 weeks ago
@joeprkns There are really five or six terms that can hurt and need looking at - not sure we need AI for this :-) - 2 weeks ago
-
Recent Posts
-
Jul 9
VC Signalling Risk in Seed Rounds -
Jun 3
Pillpack: Adding $50M in funding to bring redesigned pharmacy to all -
Feb 17
Developing London tech clusters beyond Shoreditch: Croydon ? -
Oct 2
Cytokinesis at Atlas Venture: bio and tech take off -
May 19
Zoopla at seven – how focus and speed drive exceptional outcomes
Notable Posts
-
Jul 9
Category Archives: Investors

Pillpack: Adding $50M in funding to bring redesigned pharmacy to all
There are some people in the world that it is simply a joy to work with, and when good things happened to them you can only feel joy. TJ Parker and Elliott Cohen are two such people and I’m delighted …
Comments Off on Pillpack: Adding $50M in funding to bring redesigned pharmacy to all

Why Series B is usually the hardest
Tom Tunguz and Danielle Morrill both came out with data suggesting Series B are hard. Tom calls it the “hardest round to raise”, based on his numbers. Let me try to address why that is. Let’s assume we’re in …

Pro-rata rights: the good, the bad and the ugly
Fred Wilson posted an article to explain the concept and value of pro-rata rights, with his usual elegance in making the concept clear. Pro-rata rights are incredibly valuable for a simple reason: most startup companies fail, but pro-rata rights are …

A (reconstituted) interview with Marc Andreessen
Thanks to a slightly unfortunate messaging glitch (which of you entrepreneurs would like his labor of love to be compared to “fruit fly experiments” in the Wall Street Journal), pmarca a.k.a Marc Andreessen has been drawn into in-depth conversation on HackerNews. …

On historical returns and venture capital flavours
Story of of the last few years in Venture Fund Land : large institutional investors concentrate money with fewer managers and flagship brands AND / OR find emerging managers. Since VC offerings have generally been undifferentiated, LP’s had little choice …

What's in a (venture capital) website ?
Late on Friday we launched the new website of Atlas Venture. The launch prompted me to tour our VC brethren in the Boston area and was surprised at how many have been redesigned recently: NorthBridge, General Catalyst, Charles River or …

Fund profile: Fidelity Growth Partners (Europe)
Today I am profiling the fund of my friend and co-investor Davor Hebel who is an investor with Fidelity Growth Partners Europe. Davor is a super smiley Croatian. HBS-grad as most of the venture community it seems, but I would …
Comments Off on Fund profile: Fidelity Growth Partners (Europe)

Late-stage comeback: Acton Capital Partners in €150M final close of new fund
Great news for European entrepreneurs of the later stage variety: Acton Capital Partners closes on a EUR 150M maiden fund, the so-called Heureka Growth Fund, presumably named after the discovery of gold in California rather than Archimedes running naked through …
Comments Off on Late-stage comeback: Acton Capital Partners in €150M final close of new fund